You are here

Article info

Article menu

Download PDFPDF

Case Report
Response to single agent PD-1 inhibitor after progression on previous PD-1/PD-L1 inhibitors: a case series

Authors

  • Dylan J. Martini Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School 450 Brookline Ave D1230 02215 Boston MA USA PubMed articlesGoogle scholar articles
  • Aly-Khan A. Lalani Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School 450 Brookline Ave D1230 02215 Boston MA USA PubMed articlesGoogle scholar articles
  • Dominick Bossé Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School 450 Brookline Ave D1230 02215 Boston MA USA PubMed articlesGoogle scholar articles
  • John A. Steinharter Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School 450 Brookline Ave D1230 02215 Boston MA USA PubMed articlesGoogle scholar articles
  • Lauren C. Harshman Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School 450 Brookline Ave D1230 02215 Boston MA USA PubMed articlesGoogle scholar articles
  • F. Stephen Hodi Melanoma Center, Dana-Farber Cancer Institute, Harvard Medical School Boston MA USA Center for Immuno-Oncology, Dana-Farber Cancer Institute, Harvard Medical School 450 Brookline Ave 02215 Boston MA USA PubMed articlesGoogle scholar articles
  • Patrick A. Ott Melanoma Center, Dana-Farber Cancer Institute, Harvard Medical School Boston MA USA Center for Immuno-Oncology, Dana-Farber Cancer Institute, Harvard Medical School 450 Brookline Ave 02215 Boston MA USA PubMed articlesGoogle scholar articles
  • Toni K. Choueiri Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School 450 Brookline Ave D1230 02215 Boston MA USA PubMed articlesGoogle scholar articles
  1. ↵a DylanJ_Martini{at}dfci.harvard.edu
  2. ↵b Aly-Khan_Lalani{at}dfci.harvard.edu
  3. ↵c Dominick_Bosse{at}dfci.harvard.edu
  4. ↵d JohnA_Steinharter{at}dfci.harvard.edu
  5. ↵e LaurenC_Harshman{at}dfci.harvard.edu
  6. ↵f Stephen_Hodi{at}dfci.harvard.edu
  7. ↵h Toni_Choueiri{at}dfci.harvard.edu
View Full Text

Citation

Martini DJ, Lalani AA, Bossé D, et al
Response to single agent PD-1 inhibitor after progression on previous PD-1/PD-L1 inhibitors: a case series
Journal for ImmunoTherapy of Cancer 2017;5:66. doi: 10.1186/s40425-017-0273-y

Publication history

  • Received June 1, 2017
  • Accepted August 1, 2017
  • First published August 15, 2017.
Online issue publication 
February 09, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© The Author(s). Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.